Literature DB >> 10642521

Leukotriene A4 hydrolase: a critical role of glutamic acid-296 for the binding of bestatin.

M Andberg1, A Wetterholm, J F Medina, J Z Haeggström.   

Abstract

Leukotriene A(4) hydrolase is a bifunctional Zn(2+)-containing enzyme catalysing the formation of the potent chemotaxin leukotriene B(4). From an analysis of three mutants of Glu-296 we have found that this catalytic residue is critical for the binding of bestatin, a classical aminopeptidase inhibitor. For bestatin, but not for three other tight-binding inhibitors, the IC(50) values for inhibition of the epoxide hydrolase activity decreased in the mutants to 0.7-0.003% of the control. Hence Glu-296 is an important structural determinant for binding of bestatin to leukotriene A(4) hydrolase; this conclusion might also apply to other members of the M1 family of metallopeptidases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10642521      PMCID: PMC1220797     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  22 in total

Review 1.  Zinc coordination, function, and structure of zinc enzymes and other proteins.

Authors:  B L Vallee; D S Auld
Journal:  Biochemistry       Date:  1990-06-19       Impact factor: 3.162

2.  Leukotriene A4 hydrolase: protection from mechanism-based inactivation by mutation of tyrosine-378.

Authors:  M J Mueller; M Blomster; U C Oppermann; H Jörnvall; B Samuelsson; J Z Haeggström
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

3.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

4.  The graphical determination of K m and K i .

Authors:  M Dixon
Journal:  Biochem J       Date:  1972-08       Impact factor: 3.857

5.  Molecular cloning and amino acid sequence of rat kidney aminopeptidase M: a member of a super family of zinc-metallohydrolases.

Authors:  B Malfroy; H Kado-Fong; C Gros; B Giros; J C Schwartz; R Hellmiss
Journal:  Biochem Biophys Res Commun       Date:  1989-05-30       Impact factor: 3.575

6.  Design of novel inhibitors of aminopeptidases. Synthesis of peptide-derived diamino thiols and sulfur replacement analogues of bestatin.

Authors:  E M Gordon; J D Godfrey; N G Delaney; M M Asaad; D Von Langen; D W Cushman
Journal:  J Med Chem       Date:  1988-11       Impact factor: 7.446

7.  Amino hydroxamic acids as potent inhibitors of leukotriene A4 hydrolase.

Authors:  J H Hogg; I R Ollmann; J Z Haeggström; A Wetterholm; B Samuelsson; C H Wong
Journal:  Bioorg Med Chem       Date:  1995-10       Impact factor: 3.641

8.  Leukotriene A4 hydrolase: mapping of a henicosapeptide involved in mechanism-based inactivation.

Authors:  M J Mueller; A Wetterholm; M Blomster; H Jörnvall; B Samuelsson; J Z Haeggström
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

9.  Aminopeptidase-B in the rat testes: isolation, functional properties and cellular localization in the seminiferous tubules.

Authors:  S Cadel; A R Pierotti; T Foulon; C Créminon; N Barré; D Segrétain; P Cohen
Journal:  Mol Cell Endocrinol       Date:  1995-04-28       Impact factor: 4.102

10.  Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation.

Authors:  B Samuelsson
Journal:  Science       Date:  1983-05-06       Impact factor: 47.728

View more
  1 in total

Review 1.  Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological evaluations, and therapeutic prospects.

Authors:  Brigitte Bauvois; Daniel Dauzonne
Journal:  Med Res Rev       Date:  2006-01       Impact factor: 12.944

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.